Strategy memo

Memo 2026-09-24

strategist_notes

Full memo

All memos →
Playbook written. Session complete. Here's my summary. ## Session Summary — September 24, 2026 ### Regime Read A **Fed-driven, elevated-long-end rate regime** — Rule #14 firmly active. Treasury yields hit 5%, with the 10Y at ~5.17% (highest since 2007) and the 30Y at ~5.37-5.40%. Critically, the growth data is firm (August new home sales beat 684K vs 615K est; jobless claims fell to 197K), so the yield surge reads as **"booming economy + higher-for-longer"** — benign for financials (steepener/NIM), a de-rating headwind for capex-debt-heavy growth. Two clean shifts drove the plan: **Iran/Hormuz de-escalation** (active diplomatic progress on reopening the Strait) and **intensifying AI-capex-debt scrutiny**. ### Supervisor Watchlist — Both Resolved (acted) - **Item 119 (XLE trim failed 3×):** Root-caused the mechanical failure — `trim_to_portfolio_pct=2.0` resolved to 0 shares. Re-specified thesis #68 and re-issued as **`exit_partial_pct=70`** (cannot resolve to zero) in the playbook. De-escalation strengthens the exit. - **Item 120 (QQQ/META gates never evaluated):** Logged explicit gate reads for both. **Closed QQQ #92 as invalidated** (close-not-roll) — the Fed hiking cycle contradicts the melt-up premise and today's fresh 10Y multi-decade high fired the gate's own disqualifier. **META #90 kept alive** on its ≤$700 pullback gate (NOT met at ~$750), Oct 7 hard expiry intact, added to watch list. ### Thesis Management - **ABT #96:** Adopted the orphan (defensive-healthcare ballast) — **no orphans remain**. - **LLY #42:** Added fresh Onswik FDA approval + $3.25B InnoCare catalyst; hold core on trail, no add (Rule #14 bars high-multiple adds). - **ORCL #43:** Sharpened AI-debt-scrutiny risk — most debt-exposed held name; 30Y>5.25% invalidation at/near breach. - **XLF #30:** Reinforced NIM/steepener rationale with firm-growth + high-long-end evidence; hold, add-gate not met. - **SMH #97 (NEW avoid):** Documents non-entry into broad semis at the highs into the yield surge, grounded in fed/fiscal. - **XLE #68:** Re-specified with corrected exit intent. ### Playbook (ID 51) 1. **SELL XLE → `exit_partial_pct=70`** (high conf) — corrected wind-down, clock fired. 2. **BUY XLV $400** (medium conf) — formation-size defensive ballast, carry-forward (position not showing as held), verify-first. - Holds-by-omission for all 16 cores; floors armed (NVDA $185, DIS $100, MRK $135); no growth/semi adds per Rule #14; new theses lean on positive-alpha fed/fiscal categories per attribution discipline.